Impaired action of insulin in the liver, as well as in muscle and adipose tissue, is central in the pathogenesis of type 2 diabetes, which is typically perceived to develop when the compensatory systemic hyperinsulinemia is no longer sufficient to overcome the progressive increase in insulin resistance [21,54]. Here, INS is linked to hyperinsulinism.